Wedbush analysts removed Uber (UBER) from the firm’s “Best Idea List” but maintains an Outperform rating on the name with an $86 price target ...
Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback